Sandeep Laumas, M.D.
Executive Chairman and Chief Executive Officer
Sandeep Laumas
Dr. Laumas joined Private Innovate in 2014 as its executive chairman and as a member of its board of directors, and became our executive chairman and a member of our board of directors in connection with the completion of the Merger. In August 2007, Dr. Laumas founded Bearing Circle Capital, LP, an investment partnership, and has served as its managing director since such time. Dr. Laumas began his career at Goldman Sachs & Co. in 1996 as an equity analyst in the healthcare investment banking division working on mergers, acquisitions and corporate finance transactions before transitioning to the healthcare equity research division. After leaving Goldman Sachs Dr. Laumas moved to the buy side as an analyst at Balyasny Asset Management from 2001 to 2003. Dr. Laumas was a managing director of North Sound Capital from 2003 to 2007, where he was responsible for the global healthcare investment portfolio. From February 2011 to 2012, he was a member of the board of directors of Super Religare Laboratories Limited, Southeast Asia’s largest clinical laboratory service company. Dr. Laumas serves as an independent director on the board of directors of BioXcel Therapeutics, Inc. (Nasdaq: BTAI) and also served as a director of Parkway Holdings Ltd. (acquired by IHH Healthcare for $3 Billion: Singapore: IHH) from May through August 2010. Dr. Laumas received his A.B. in chemistry from Cornell University in 1990, M.D. from Albany Medical College in 1995, with a research gap year at the Dana-Farber Cancer Institute, and completed his medical internship in 1996 from the Yale University School of Medicine. We believe that Dr. Laumas’s prior board service and years of experience investing in the healthcare industry qualifies Dr. Laumas to serve on our board of directors.
Chairman of the Board
    Jay P. Madan, M.S.
    Founder, President and Chief Business Officer
    Jay P. Madan
    Mr. Madan founded Private Innovate in 2012 and began serving as its president and as a member of its board of directors at such time, and he became our president and a member of our board of directors in connection with the completion of the Merger. In March 2018, Mr. Madan was also appointed as our chief business officer and serves as our interim principal financial officer and interim principal accounting officer. Prior to founding Private Innovate, Mr. Madan was an independent contractor advising multiple life sciences companies, including Reliance Life Sciences, Millipore, Baxter, Dade Behring and Goodwin. This experience in working across multiple teams led him to develop a global network of healthcare professionals. From July 2007 to November 2008, Mr. Madan served as the vice president of business development at Reliance Biopharmaceuticals Pvt. Ltd., a part of Reliance Industries Ltd., India's largest conglomerate. While at Reliance and Goodwin, Mr. Madan was focused on the development of their contract manufacturing businesses. Mr. Madan holds a B.S. in chemical engineering from University of Mumbai and an M.S. in chemical engineering from Washington State University. We believe that Mr. Madan's role as a founder of lnnovate and extensive experience in the life sciences and biotech industries qualifies him to serve on our board of directors.
    Financial Expert
      Ed Sitar
      Chief Financial Officer
      Ed Sitar
      Mr. Sitar became our Chief Financial Officer in July 2019. Most recently he served as the Chief Financial Officer of Ammon Analytical Laboratory, a company focused on specialty testing for the drug treatment community, from April 2017 to November 2018. Previously, he served as the Chief Financial Officer of Cancer Genetics, Inc. (Nasdaq: CGIX), a company focused on precision medicine for oncology, from March 2014 until February 2017. Prior to his service at Cancer Genetics, he served from January 2010 to December 2013 as the Chief Financial Officer-New Business of Healthagen, an Aetna company offering health products and services, and served as Chief Financial Officer of ActiveHealth Management from August 2010 to December 2012. From April 2001 to May 2010, he served as Executive Vice President and Chief Financial Officer of Cadent Holdings, Inc., a privately held company that provided three-dimensional digital scanning services for dentists and orthodontists. From August 1998 to April 2001, Mr. Sitar served as Chief Financial Officer and Treasurer of MIM Corporation, now BioScrip, Inc., a publicly traded specialty pharmaceutical and pharmacy benefit management service provider. From May 1996 to August 1998, Mr. Sitar was the Vice President of Finance for Vital Signs, Inc., a publicly traded manufacturer and distributor of single use medical products, which is now part of GE Healthcare . From June 1993 to April 1996, Mr. Sitar was the Controller of Zenith. From 1983 through July 1993, he was with Coopers & Lybrand, a public accounting firm. He holds a B.S. in accounting from the University of Scranton and is licensed as a Certified Public Accountant in New Jersey.  Mr. Sitar was the 2015 NJBIZ CFO of the Year.
        Patrick H. Griffin, M.D. FACP.
        Chief Medical Officer
        Patrick H. Griffin, M.D. FACP.
        Dr. Griffin became our chief medical officer in February 2019. Previously, Dr. Griffin served as executive vice president and chief medical officer of Synergy Pharmaceuticals from January 2015 through November 2018, and senior vice president and chief medical officer May 2013 through January 2015. From March 2012 to April 2013, Dr. Griffin served as chief medical officer and senior vice president of development at ImmusanT, Inc. From March 2009 until January 2012, Dr. Griffin served as associate vice president, clinical development and head of external innovation at Sanofi-Aventis (now Sanofi). He is a board-certified physician in both internal medicine and gastroenterology, and is a Fellow of the American College of Physicians. He received his medical degree from Columbia University, completing a residency in internal medicine at Presbyterian Hospital in New York, and a fellowship in gastroenterology at Brigham and Women's Hospital in Boston. Following his residency and fellowship, Dr. Griffin joined the medical faculty of Columbia College of Physicians and Surgeons, where he held a number of academic, clinical research, teaching and management positions, and a private practice in New York.
          Kendyle Woodard, MBA
          Co-founder and Executive Vice President, Corporate Affairs

          Ms. Woodard co-founded Private Innovate in 2012 and began serving as its director, and she became our executive vice president of corporate affairs and corporate secretary in connection with the completion of the Merger. Ms. Woodard oversees the company’s operations. Ms. Woodard has more than 15 years of experience in business operations and marketing supporting startups, non-profits, manufacturers, and consulting companies. She was the vice president of iBiotech, Inc. working with clients on technology development, operations, marketing, and business development. Ms. Woodard assisted in the management and operations of several startup companies and with the commercialization of university technologies. As the director of marketing for the NC Biotechnology Center she positioned North Carolina as a world leader in life sciences to support the state’s economic development initiatives. Ms. Woodard earned her B.S. degree, magna cum laude, in international business and marketing from University of South Alabama and was awarded her M.B.A. degree, cum laude, from North Carolina State University. Ms. Woodard co-founded the NC State University and Triangle professional chapters of Net Impact and is a past board member of the NC State University MBA Alumni and Women in Bio’s Triangle chapter. Ms. Woodard currently serves as board chair of Adaptive Risk Systems, Inc. and is a member of BIO’s Technology Transfer Committee.

            We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy. 

            Cookie Policy

            Copyright West LLC. Minimum 15 minutes delayed.